“Efficacy and Safety of Dapagliflozin As Adjunct Therapy in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea”. Academia Journal of Medicine, vol. 9, no. 2, Oct. 2026, pp. 201-5, https://doi.org/10.48165/ajm.2026.9.02.34.